PubRank
Search
About
G R Kitchingman
Author PubWeight™ 40.86
‹?›
Top papers
Rank
Title
Journal
Year
PubWeight™
‹?›
1
The structure of adenovirus 2 early nuclear and cytoplasmic RNAs.
J Mol Biol
1980
2.74
2
Loop structures in hybrids of early RNA and the separated strands of adenovirus DNA.
Proc Natl Acad Sci U S A
1977
2.60
3
Mutations in the mu heavy-chain gene in patients with agammaglobulinemia.
N Engl J Med
1996
2.10
4
Transmembrane orientation of glycoproteins encoded by the v-fms oncogene.
Cell
1985
1.41
5
Extensive cross-reactivity of adenovirus-specific cytotoxic T cells.
Hum Gene Ther
1998
1.34
6
Modification-deficient transfer ribonucleic acids from relaxed control Escherichia coli: structures of the major undermodified phenylalanine and leucine transfer RNAs produced during leucine starvation.
Biochemistry
1977
1.17
7
Rearrangement of immunoglobulin heavy chain genes in T cell acute lymphoblastic leukemia.
Blood
1985
1.06
8
Adenovirus-pulsed dendritic cells stimulate human virus-specific T-cell responses in vitro.
J Virol
1996
1.04
9
Childhood acute lymphoblastic leukemia with chromosomal breakpoints at 11q23.
Blood
1989
0.96
10
Sequence of the DNA-binding protein of a human subgroup E adenovirus (type 4): comparisons with subgroup A (type 12), subgroup B (type 7), and subgroup C (type 5).
Virology
1985
0.96
11
Localization of adenovirus-encoded DNA replication proteins in the nucleus by immunogold electron microscopy.
J Gen Virol
1990
0.95
12
Unique phenylalanine transfer ribonucleic acids in relaxed control Escherichia coli: genetic origin and some functional properties.
Biochemistry
1976
0.92
13
Unbalanced growth and the production of unique transfer ribonucleic acids in relaxed-control Escherichia coli.
J Bacteriol
1975
0.89
14
Detection of minimal residual disease in T-cell acute lymphoblastic leukemia using polymerase chain reaction predicts impending relapse.
Blood
1991
0.89
15
Abnormalities of the long arm of chromosome 6 in childhood acute lymphoblastic leukemia.
Blood
1990
0.89
16
Biologic and prognostic significance of the presence of more than two mu heavy-chain genes in childhood acute lymphoblastic leukemia of B precursor cell origin.
Blood
1986
0.89
17
Acute myeloid leukemia with T-lymphoid features: a distinct biologic and clinical entity.
Blood
1988
0.89
18
Biochemical analysis of adenovirus type 5 DNA-binding protein mutants.
J Biol Chem
1989
0.88
19
Functional analysis of the adenovirus type 5 DNA-binding protein: site-directed mutants which are defective for adeno-associated virus helper activity.
J Virol
1986
0.87
20
mRNA transcripts initiating within the human immunoglobulin mu heavy chain enhancer region contain a non-translatable exon and are extremely heterogeneous at the 5' end.
Nucleic Acids Res
1991
0.87
21
Conserved region 3 of the adenovirus type 5 DNA-binding protein is important for interaction with single-stranded DNA.
J Virol
1990
0.85
22
Restriction mapping and molecular cloning of adenovirus type 4 (subgroup E) DNA.
Gene
1982
0.85
23
In vivo maturation of an undermodified Escherichia coli leucine transfer RNA.
Biochem Biophys Res Commun
1976
0.82
24
14q32 translocations are associated with mixed-lineage expression in childhood acute leukemia.
Blood
1990
0.81
25
Bidirectional transcription from the human immunoglobulin VH6 gene promoter.
Nucleic Acids Res
1994
0.81
26
Temperature-sensitive mutants of adenovirus single-stranded DNA-binding protein. Inability to support DNA replication is associated with an altered DNA-binding activity of the protein.
J Biol Chem
1991
0.81
27
Provocative pattern of rearrangements of the genes for the gamma and beta chains of the T-cell receptor in human leukemias.
Proc Natl Acad Sci U S A
1987
0.80
28
Minimal residual disease after intensive induction therapy in childhood acute lymphoblastic leukemia predicts outcome.
Leukemia
1998
0.80
29
Sequence of the DNA-binding protein gene of a human subgroup B adenovirus (type 7). Comparisons with subgroup C (type 5) and subgroup A (type 12).
J Biol Chem
1984
0.80
30
The clinical significance of residual disease in childhood acute lymphoblastic leukemia as detected by polymerase chain reaction amplification by antigen-receptor gene sequences.
Leuk Lymphoma
1996
0.80
31
Wild-type p53 induction mediated by replication-deficient adenoviral vectors.
Cancer Res
1999
0.78
32
Alterations in immunoglobulin or T cell receptor gene rearrangement at relapse: involvement of 11q23 and changes in immunophenotype.
Leukemia
1990
0.78
33
Isolation of activated ras transforming genes from two patients with Hodgkin's disease.
Int J Radiat Oncol Biol Phys
1985
0.78
34
A monoclonal antibody to a novel surface antigen, MKW, blocks the antiproliferative and differentiation effects of granulocyte-macrophagecolony-stimulating factor and vitamin D3.
Blood
1992
0.78
35
Clonal analysis of childhood acute lymphoblastic leukemia with "cytogenetically independent" cell populations.
J Clin Invest
1989
0.78
36
Characterization of immunoglobulin heavy chain genes from an acute lymphocytic leukemia with four rearrangements.
Leukemia
1991
0.77
37
Analysis of the imperfect octamer-containing human immunoglobulin VH6 gene promoter.
Nucleic Acids Res
1994
0.77
38
Inhibition of post-transcriptional modification of E. coli tRNA.
Brookhaven Symp Biol
1975
0.77
39
Functional changes in temperature-sensitive mutants of the adenovirus single-stranded DNA-binding protein are accompanied by structural alterations.
J Virol
1992
0.77
40
Sequencing of selected regions of the human immunoglobulin heavy-chain gene locus that completes the sequence from JH through the delta constant region.
DNA Seq
1991
0.76
41
Mixed lineage leukemia: the implications for hematopoietic differentiation.
Blood
1986
0.76
42
Monitoring residual disease in acute lymphoblastic leukemia: therapeutic implications.
Cytokines Mol Ther
1995
0.75
43
General and specific effects of amino acid starvation on the formation of undermodified Escherichia coli phenylalanine tRNA.
Biochim Biophys Acta
1976
0.75
44
Detection of minimal residual disease in all: biology, methods, and applications.
Cancer Treat Res
1996
0.75